GMRE vs NXRT

For growth investors, Global Medical REIT Inc.

(GMRE) is the stronger pick with -1. 8% revenue growth year-over-year, versus -3. 2% for NexPoint Residential Trust, Inc. (NXRT). Global Medical REIT Inc. (GMRE) offers the better valuation at 115. 3x trailing P/E (595. 7x forward), making it the more compelling value choice. Analysts rate Global Medical REIT Inc. (GMRE) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Global Medical REIT Inc.

(GMRE) delivered a total return of -19. 8%, compared to -21. 7% for NexPoint Residential Trust, Inc. (NXRT). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus NXRT's +211. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Global Medical REIT Inc.

(GMRE) is the lower-risk stock at 0. 48β versus NexPoint Residential Trust, Inc. 's 0. 62β — meaning NXRT is approximately 30% more volatile than GMRE relative to the S&P 500. On balance sheet safety, Global Medical REIT Inc. (GMRE) carries a lower debt/equity ratio of 118% versus 5% for NexPoint Residential Trust, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Global Medical REIT Inc.

(GMRE) is pulling ahead at -1. 8% versus -3. 2% for NexPoint Residential Trust, Inc. (NXRT). On earnings-per-share growth, the picture is similar: Global Medical REIT Inc. grew EPS -94. 6% year-over-year, compared to -30. 8% for NexPoint Residential Trust, Inc.. Over a 3-year CAGR, GMRE leads at 6. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Global Medical REIT Inc.

(GMRE) is the more profitable company, earning 4. 8% net margin versus -12. 7% for NexPoint Residential Trust, Inc. — meaning it keeps 4. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GMRE leads at 23. 6% versus 11. 1% for NXRT. At the gross margin level — before operating expenses — NXRT leads at 84. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for GMRE: 11.

9% to $40. 00.

All stocks in this comparison pay dividends.

Global Medical REIT Inc. (GMRE) offers the highest yield at 63. 5%, versus 7. 1% for NexPoint Residential Trust, Inc. (NXRT).

For long-horizon retirement investors, Global Medical REIT Inc.

(GMRE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 48), 63. 5% yield, +308. 1% 10Y return). Both have compounded well over 10 years (GMRE: +308. 1%, NXRT: +211. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.